About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials | 4,789 Studies Recruiting

Clinical TrialsPancreatic Cancer

Pancreatic Cancer Clinical Trials

Browse 4,789 clinical trials for pancreatic cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4021-4040 of 4,789 trials

UnknownPerioperative Intervention to Reduce Metastatic Processes in Pancreatic Cancer Patients Undergoing Curative SurgeryIn Israel, of the \~1000 patients diagnosed annually with pancreatic cancer (PC), approximately 250 (25 percent) will be eligible for curative surgery, of which 80 percent will…NCT03838029·Tel Aviv and 2 others

Related Searches

pancreas cancertrials

Data from ClinicalTrials.govTerms

UnknownBiodegradable Pancreatic Stents for the Prevention of Postoperative Pancreatic Fistula After Cephalic PancreaticoduodenectomyBackground: postoperative pancreatic fistula (POPF) remains the most important morbidity after pancreaticoduodenectomy (PD).NCT04783831·Murcia

Active not recruitingStudy of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid TumorsINDP-D101 is a Phase 1/2, open-label, multi-center, dose escalation and expansion study evaluating the safety, tolerability and clinical activity of Decoy20 as monotherapy and in…NCT05651022·Los Angeles, California and 11 others

CompletedCohort Study on Nutritional, Metabolic, and Volumetric Assessment After PancreaticoduodenectomyPeriampullary malignant neoplasms are among the most lethal gastrointestinal tumors. They are usually diagnosed at advanced stages and require complex surgical treatment.NCT07159672·Ribeirão Preto, São Paulo

TerminatedEndoscopic Ultrasound (EUS) Guided Fine Needle Aspiration (FNA) EUS-FNA of Solid Pancreatic Mass Lesions Using a Novel Corkscrew Technique: a Pilot StudyThis research is being done to investigate if a new technique to biopsy the pancreas will lead to a larger amount tissue material that can be analyzed.NCT02116322·Baltimore, Maryland

Not yet recruitingComparing Astragalus Plus Gemcitabine to Gemcitabine Alone as Neoadjuvant Treatment for Pancreatic Cancer PatientsThis study compare the efficacy of Astragalus combined with Gemcitabine to Gemcitabine alone as neoadjuvant treatment for pancreatic cancer.NCT06234072·Shenzhen, Guangdong

Active not recruitingSerum DCAMKL1 Pre and Post Treatment in Patients With Pancreatic CancerThe investigators believe DCAMKL-1 is a stem cell tumor marker and is elevated in patients with pancreatic cancer.NCT01580241·Oklahoma City, Oklahoma

CompletedChromogranin A as Blood Marker in Cancer PatientsGastroentero-pancreatic neuroendocrine tumors (GEP-NETs) are a heterogenous group of neoplasms that arise from enterochromaffin cells of the gastrointestinal (GI) tract and…NCT03817866·Palo Alto, California and 3 others

UnknownVactosertib With Nal-IRI/FL in Metastatic Pancreatic Ductal Adenocarcinoma.To determine recommended phase 2 dose and to evaluate the safety of vactosertib in combination with nal-IRI/FL in patients with metastatic pancreatic ductal adenocarcinoma (PDAC)…NCT04258072·Seoul

UnknownAutoimmune Pancreatitis, Pancreatic and Extrapancreatic cAnceR (AiPPEAR)The goal of this observational, retrospective study is to learn about cancer risk in autoimmune pancreatitis (AIP) patients.NCT06328101

CompletedIrinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid TumorsRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00004095·Chicago, Illinois

CompletedVitamin E δ-Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine NeoplasiaThe purpose of this study is to determine the safest dose of the study drug Vitamin E Delta-tocotrienol, how often it should be taken, and how well people with pancreatic tumors…NCT00985777·Tampa, Florida

Not yet recruitingA Study of CLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101)Phase 1, open-label, multicenter study to evaluate the safety, tolerability, PK, PD, and preliminary clinical activity of CLSP 5282 when administered to HLA A\*03:01-positive…NCT07650357·Durham, North Carolina and 3 others

RecruitingSurvival, Quality of Life and Resectability in Locally Advanced Pancreatic CancerThis study aims to assess overall survival, quality of life and resection rates in locally advanced pancreatic cancerNCT05356039·Umeå

UnknownOrganoid-Guided Chemotherapy for Advanced Pancreatic CancerThe purpose of this study is to explore whether chemotherapy regimens guided by organoid drug sensitivity test can improve the outcomes of advanced pancreatic cancer.NCT04931381·Shanghai

CompletedPalliadelic Treatment to Reduce Psychological Distress in Persons With Advanced Gastrointestinal CancersThe primary objective of this study is to evaluate the ability to recruit and retain participants, and to successfully conduct a psilocybin-based protocol, for a study of the…NCT05220046·Omaha, Nebraska

WithdrawnNeoantigen-Targeted Vaccine Combined With Anti-PD-1 Antibody for Patients With Stage IV MMR-p Colon and Pancreatic Ductal CancerPhase 1 study evaluating feasibility, safety, and immune response to a personalized neoantigen vaccine combined with retifanlimab for MMR-p mCRC and mPDAC patients with measurable…NCT04799431

Active not recruitingIMPact of AerobiC Exercise in Addition to Nutritional Treatment on Quality of Life After PancreatectomyThe goal of this interventional study is to assess the impact of a 6-month unsupervised aerobic exercise program on the quality of life of patients undergoing partial or total…NCT06858631·Rome, RM

CompletedA Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BKM120 Plus GSK1120212 in Selected Advanced Solid Tumor PatientsThis is an open label, dose finding, phase Ib clinical trial to determine the maximum tolerated dose (MTD) and /or recommended phase II dose (RP2D) and schedule for the PI3K…NCT01155453·Los Angeles, California and 6 others

TerminatedS-1 Versus 5-FU Bolus in Metastatic Pancreatic Cancer Patients Previously Treated With Gemcitabine-Based RegimenThe primary objective of this study is to determine whether S-1 increases overall survival when compared to 5-Fluorouracil (5-FU) in patients with metastatic pancreatic cancer…NCT00602745·Bridgewater, New Jersey and 16 others

PreviousPage 202 of 240Next